Bioteque (ROCO:4107) Cash Flow for Dividends: NT$-346 Mil (TTM As of Dec. 2025)


ROCO:4107 Bioteque Corp ROCO:4107
84 GF Score
Price NT$116.50
GF Value NT$129.03
Valuation Modestly Undervalued
View Full Analysis

What is Bioteque Cash Flow for Dividends?

Bioteque ROCO:4107 +0.87% 84 Cash Flow for Dividends is NT$-346 Mil as of Dec. 2025. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.03 (Modestly Undervalued).

Bioteque's cash flow for dividends for the three months ended in Dec. 2025 was NT$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-346 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Bioteque's quarterly payment of dividends increased from Jun. 2025 (NT$0 Mil) to Sep. 2025 (NT$-346 Mil) but then declined from Sep. 2025 (NT$-346 Mil) to Dec. 2025 (NT$0 Mil).

Bioteque's annual payment of dividends stayed the same from Dec. 2023 (NT$-312 Mil) to Dec. 2024 (NT$-312 Mil) but then increased from Dec. 2024 (NT$-312 Mil) to Dec. 2025 (NT$-346 Mil).

Bioteque Cash Flow for Dividends Related Terms

Bioteque Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Bioteque's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque Cash Flow for Dividends Chart

Bioteque Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -277.19 -311.84 -311.84 -311.84 -346.49

Bioteque Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -346.49 0.00
ROCO:4107
84GF Score
Bioteque Corp ROCO:4107
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-346 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$-346 Mil mean?
Bioteque (ROCO:4107) has a Cash Flow for Dividends of NT$-346 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bioteque and its competitors.
Is Bioteque's Cash Flow for Dividends too high?
Bioteque's current Cash Flow for Dividends is NT$-346 Mil. Overall, Bioteque has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Cash Flow for Dividends compare to ISRG and BDX?
Bioteque's Cash Flow for Dividends of NT$-346 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bioteque and its competitors. Bioteque's current Cash Flow for Dividends is NT$-346 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.03, compared to a current price of NT$116.50 — trading 9.7% below its estimated fair value. The current Cash Flow for Dividends is NT$-346 Mil. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Cash Flow for Dividends is NT$-346 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$116.50 is trading 9.7% below its estimated GF Value™ of NT$129.03. GuruFocus considers Bioteque to be Modestly Undervalued.

Key valuation signals for ROCO:4107:

  • Cash Flow for Dividends: NT$-346 Mil
  • GF Value™: NT$129.03 vs. price of NT$116.50 (9.7% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score

Get the complete analysis for ROCO:4107

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$116.50
Price
NT$129.03
GF Value